Letters to the Editor

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party

Cliniques Universitaires St. Luc, Brussels
EBMT Paris Study Unit, Paris, France; Complications Working Party of the EBMT
Universita Cattolica S. Cuore, Rome
Hopital Bretonneau, Tours
UO Ematologia e Terapie Cellulari, IRCCS Azienda Ospedaliera Metropolitana, Ospedale Policlinico San Martino, Genova
Kantonsspital St.Gallen, St. Gallen
Department of Hematology, Oncology Institute of Southern Switzerland, Ospedale Regionale Bellinzona e Valli, Bellinzona
EBMT Paris Study Unit, Paris, France; Complications Working Party of the EBMT
EBMT Paris Study Unit, Paris, France; Complications Working Party of the EBMT
Complications Working Party of the EBMT; RM Gorbacheva Research Institute, Pavlov University, St Petersburg, Russia
Complications Working Party of the EBMT; Department of Hematology, University Hospitals Leuven, Leuven, Belgium; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery (AccentVV), KU Leuven, Leuven
Complications Working Party of the EBMT; Institut Català d'Oncologia de l'Hospital Duran i Reynals (ICO-DiR), L'Hospitalet de Llobregat, Barcelona
Complications Working Party of the EBMT; Department of Hematology, Rijeka University Hospital Centre, Rijeka, Croatia
Complications Working Party of the EBMT; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Complications Working Party of the EBMT; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London
Complications Working Party of the EBMT; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Augustenburger Platz, Berlin
Haematologica Early view Jul 16, 2026 https://doi.org/10.3324/haematol.2026.301337